These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6354441

  • 21. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, Herrmann R, Greil R, Anselmo AP, Diehl V.
    J Clin Oncol; 2002 Jan 15; 20(2):476-84. PubMed ID: 11786577
    [Abstract] [Full Text] [Related]

  • 22. Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
    Postmus PE, Splinter TA, Palmen FM, Carney DN, Festen J, Burghouts JT, Vendrik C, Roozendaal K, Planting AS, Quoix E.
    Eur J Cancer; 1992 Jan 15; 28(1):96-100. PubMed ID: 1314632
    [Abstract] [Full Text] [Related]

  • 23. The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
    Wolf M, Havemann K, Holle R, Harms V, Drings P, Hans K, Dombrowski H, Victor N.
    Eur J Cancer Clin Oncol; 1987 Aug 15; 23(8):1197-205. PubMed ID: 2443363
    [Abstract] [Full Text] [Related]

  • 24. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Elisson LO, Ekberg L.
    Semin Oncol; 1995 Feb 15; 22(1 Suppl 2):15-7. PubMed ID: 7846536
    [Abstract] [Full Text] [Related]

  • 25. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
    Mukaiyama T, Ogawa M, Horikoshi N, Inoue K, Tada A, Ueno K, Yamazaki H, Nakamura T, Ito Y, Inagaki J.
    Gan To Kagaku Ryoho; 1989 Mar 15; 16(3 Pt 1):327-32. PubMed ID: 2494947
    [Abstract] [Full Text] [Related]

  • 26. High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma.
    Lossos IS, Hosein PJ, Morgensztern D, Coleman F, Escalón MP, Byrne GE, Rosenblatt JD, Walker GR.
    Leuk Lymphoma; 2010 Mar 15; 51(3):406-14. PubMed ID: 20038221
    [Abstract] [Full Text] [Related]

  • 27. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Jürgens H, Exner U, Kühl J, Ritter J, Treuner J, Weinel P, Winkler K, Göbel U.
    Cancer Chemother Pharmacol; 1989 Mar 15; 24 Suppl 1():S40-4. PubMed ID: 2503258
    [Abstract] [Full Text] [Related]

  • 28. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 15; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 29. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
    Taytard A, Chomy P, Courty G, Gachie JP, Roquain J.
    Rev Fr Mal Respir; 1980 Aug 15; 8(3):225-32. PubMed ID: 6314444
    [Abstract] [Full Text] [Related]

  • 30. Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.
    Veronesi A, Magri MD, Tirelli U, Carbone A, Mazza F, Franceschi S, Talamini R, Ardizzoni A, Canobbio L, Rosso R.
    Am J Clin Oncol; 1988 Oct 15; 11(5):566-71. PubMed ID: 2845769
    [Abstract] [Full Text] [Related]

  • 31. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.
    J Clin Oncol; 2005 Jun 20; 23(18):4031-8. PubMed ID: 15767644
    [Abstract] [Full Text] [Related]

  • 32. Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck.
    Focan C, Le Hung S, Bays-Gallaix R, Frère MH, Demonceau G, Mbuyamba P, Salamon E, Claessens JJ.
    Cancer Treat Rev; 1983 Sep 20; 10 Suppl A():159-61. PubMed ID: 6684990
    [No Abstract] [Full Text] [Related]

  • 33. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
    Postmus PE, Smit EF, Berendsen HH, Haaxma-Reiche H.
    Semin Oncol; 1992 Feb 20; 19(1 Suppl 2):17-23. PubMed ID: 1329219
    [Abstract] [Full Text] [Related]

  • 34. Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
    Spiro SG, Souhami RL, Geddes DM, Ash CM, Quinn H, Harper PG, Tobias JS, Partridge M, Eraut D.
    Br J Cancer; 1989 Apr 20; 59(4):578-83. PubMed ID: 2540788
    [Abstract] [Full Text] [Related]

  • 35. Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
    Feld R, Evans WK, Coy P, Hodson I, MacDonald AS, Osoba D, Payne D, Shelley W, Pater JL.
    J Clin Oncol; 1987 Sep 20; 5(9):1401-9. PubMed ID: 3040923
    [Abstract] [Full Text] [Related]

  • 36. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
    Song SY, Kim WS, Kim K, Jung CW, Im YH, Kim HJ, Kang WK, Lee HG, Kwon OJ, Rhee CH, Park CH, Park K.
    Jpn J Clin Oncol; 2003 Oct 20; 33(10):509-13. PubMed ID: 14623918
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.